title: Sepsis caused by Flavimonas oryzihabitans.
abstract: Previous reports of F. oryzihabitans sepsis involving central venous access devices reveal a relatively high rate of complications, including device removal, despite a course of broad-spectrum anti-microbials with compatible in vitro susceptibility results. In the present report of 22 cases of F. oryzihabitans sepsis treated at Memorial Sloan-Kettering Cancer Center from February 1986 through September 1993, the majority of CVAD-related infections with F. oryzihabitans were successfully treated with a 14-day course of antimicrobials with antipseudomonal activity, and removal of the device was usually not required. Factors that may complicate successful treatment of CVAD-related sepsis caused by F. oryzihabitans include polymicrobial infections and premature discontinuation of antibiotic therapy.
authors.affiliation: Department of Medicine, Memorial-Sloan Kettering Cancer Center, New York, NY 10021.
authors.forename: K G
authors.initials: KG
authors.lastname: Lucas
authors.forename: T E
authors.initials: TE
authors.lastname: Kiehn
authors.forename: K A
authors.initials: KA
authors.lastname: Sobeck
authors.forename: D
authors.initials: D
authors.lastname: Armstrong
authors.forename: A E
authors.initials: AE
authors.lastname: Brown
mesh_terms: D000328:Adult; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology*; D002648:Child; D002675:Child, Preschool; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology*